AHI Viewpoint
Statement by Martha Scott Poindexter On New World Screwworm Detection in Texas
(June 4, 2026) New World Screwworm has now been detected in Texas – a serious development that U.S. animal health officials have long worked to prevent. The encouraging news is that U.S. authorities have seen this coming and have been working urgently to prepare. Since August of 2025, FDA’s Center for Veterinary Medicine (CVM) has […]
Animal Health Institute Calls for Faster, More Modern Animal Drug Review Process in ADUFA VI Discussions
Washington, DC – The Animal Health Institute (AHI) today urged regulators and stakeholders to use the upcoming reauthorization of the Animal Drug User Fee Act (ADUFA VI) as an opportunity to modernize the animal drug review process, strengthen U.S. leadership in animal health innovation, and improve timely access to safe and effective products for veterinarians, […]
AHI Statement from Martha Scott Poindexter on Presidential Proclamation of Pharmaceutical Tariffs
April 6, 2026—The Animal Health Institute today expressed appreciation to the Trump Administration for recognizing the value of animal health products in the Proclamation entitled “Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients into the United States” released on April 2, 2026. “While we are still analyzing the Proclamation we look forward to working with the […]
AHI Welcomes Dr. Ellen J. Hart as Vice President of Regulatory and International Affairs
Washington, D.C. — April 6, 2026 — The Animal Health Institute (AHI) today announced that Ellen J. Hart, DVM, has joined the organization as Vice President of Regulatory and International Affairs. In her role, Dr. Hart will lead the industry’s regulatory reform effort, coordinate industry’s efforts in anticipation of the Animal Drug User Fee Act […]















